Literature DB >> 21952810

Cancer-promoting tumor-associated macrophages: new vistas and open questions.

Alberto Mantovani1, Giovanni Germano, Federica Marchesi, Marco Locatelli, Subhra K Biswas.   

Abstract

Tumor-associated macrophages (TAMs) are key components of the tumor macroenvironment. Cancer- and host cell-derived signals generally drive the functions of TAMs towards an M2-like polarized, tumor-propelling mode; however, when appropriately re-educated. TAMs also have the potential to elicit tumor destructive reactions. Here, we discuss recent advances regarding the immunobiology of TAMs and highlight open questions including the mechanisms of their accumulation (recruitment versus proliferation), their diversity and how to best therapeutically target these cells.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21952810     DOI: 10.1002/eji.201141894

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  87 in total

Review 1.  Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti-tumor immunity.

Authors:  Laura M Sipe; Mehdi Chaib; Ajeeth K Pingili; Joseph F Pierre; Liza Makowski
Journal:  Immunol Rev       Date:  2020-05       Impact factor: 12.988

Review 2.  Pathogenesis beyond the cancer clone(s) in multiple myeloma.

Authors:  Giada Bianchi; Nikhil C Munshi
Journal:  Blood       Date:  2015-04-02       Impact factor: 22.113

3.  Baicalein suppress EMT of breast cancer by mediating tumor-associated macrophages polarization.

Authors:  Xixi Zhao; Jingkun Qu; Xu Liu; Jizhao Wang; Xingcong Ma; Xiaoyao Zhao; Qian Yang; Wanjun Yan; Zitong Zhao; Yuxin Hui; Haocheng Bai; Shuqun Zhang
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

Review 4.  Wounds that will not heal: pervasive cellular reprogramming in cancer.

Authors:  Jung S Byun; Kevin Gardner
Journal:  Am J Pathol       Date:  2013-02-22       Impact factor: 4.307

5.  Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma.

Authors:  Jeffrey Lee Jensen; Alexander Rakhmilevich; Erika Heninger; Aimee Teo Broman; Chelsea Hope; Funita Phan; Shigeki Miyamoto; Ioanna Maroulakou; Natalie Callander; Peiman Hematti; Marta Chesi; P Leif Bergsagel; Paul Sondel; Fotis Asimakopoulos
Journal:  Cancer Immunol Res       Date:  2015-05-04       Impact factor: 11.151

6.  Autocrine expression of the epidermal growth factor receptor ligand heparin-binding EGF-like growth factor in cervical cancer.

Authors:  Marlies Schrevel; E Michelle Osse; Frans A Prins; J Baptist M Z Trimbos; Gert Jan Fleuren; Arko Gorter; Ekaterina S Jordanova
Journal:  Int J Oncol       Date:  2017-05-03       Impact factor: 5.650

Review 7.  Macrophages in multiple myeloma: emerging concepts and therapeutic implications.

Authors:  Fotis Asimakopoulos; Jaehyup Kim; Ryan A Denu; Chelsea Hope; Jeffrey L Jensen; Samuel J Ollar; Ellen Hebron; Claire Flanagan; Natalie Callander; Peiman Hematti
Journal:  Leuk Lymphoma       Date:  2013-04-11

Review 8.  Role of innate immunity in the development of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 9.  Cancer-associated fibroblasts in hepatocellular carcinoma.

Authors:  Norio Kubo; Kenichiro Araki; Hiroyuki Kuwano; Ken Shirabe
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

10.  Decrease of VEGF-A in myeloid cells attenuates glioma progression and prolongs survival in an experimental glioma model.

Authors:  Nadja Osterberg; Napoleone Ferrara; Jean Vacher; Simone Gaedicke; Gabriele Niedermann; Astrid Weyerbrock; Soroush Doostkam; Hans-Eckart Schaefer; Karl H Plate; Marcia Regina Machein
Journal:  Neuro Oncol       Date:  2016-03-06       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.